Roche 454 GS Junior Sales Increase in 2011, While GS FLX Reagent Revenue Drops | GenomeWeb

By Julia Karow

This article was originally published Feb. 1.

Sales of Roche's 454 GS Junior increased in 2011 while GS FLX reagent sales declined following the system's long-read upgrade, resulting in decreased overall revenue for 454, according to a company official.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.